Tissue Regeneration Systems, a biotech spin-out of Michigan and Wisconsin, raises $4.6m from multiple backers including parents.
Biotech Tissue Regeneration Systems (TRS) has received $4.6m in series B funding in a round led by venture firm Venture Investors with participation from the universities of Wisconsin and Michigan. Founded in 2008 as a collaborative spin-out from the two institutions, TRS is developing research that assists the body in regenerating bone tissue around the…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
